CXCL10 Is Critical for the Generation of Protective CD8 T Cell Response Induced by Antigen Pulsed CpG-ODN Activated Dendritic Cells

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Majumder, Saikat ^a   Bhattacharjee, Surajit ^a   Paul Chowdhury, Bidisha ^a   Majumdar, Subrata ^a  

^a BOSE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; DENDRITIC CELL VACCINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANZYME B; PARASITE ANTIGEN; PERFORIN; PLACEBO; SOLUBLE LEISHMANIAL ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN FUNCTION; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL COUNT; CELL GROWTH; CELL PROTECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG PULSE THERAPY; IMMUNOSTIMULATION; INFECTION PREVENTION; LEISHMANIASIS; MOUSE; NONHUMAN; PARASITE LOAD; PROTEIN FUNCTION; PROTEIN SYNTHESIS; VACCINATION;

ANIMALS; ANTIGENS, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CXCL10; DENDRITIC CELLS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; LEISHMANIASIS VACCINES; LEISHMANIASIS, VISCERAL; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES;

LEISHMANIA DONOVANI; MURINAE; MUS;

EID: 84868702108     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048727     Document Type: Article

References (43)

1. Palucka K, Banchereau J, (1999) Dendritic cells: a link between innate and adaptive immunity. J Clin Immunol 19: 12-25.
2. Flohé SB, Bauer C, Flohé S, Moll H, (1998) Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major. Eur J Immunol 28: 3800-3811.
3. Ahuja SS, Reddick RL, Sato N, Montalbo E, Kostecki V, et al. (1999) Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection. J Immunol 163: 3890-3897.
4. Moll H, Berberich C, (2001) Dendritic cell-based vaccination strategies: induction of protective immunity against leishmaniasis. Immunobiology 204: 659-666.
5. Takeda K, Kaisho T, Akira S, (2003) Toll-like receptors. Annu Rev Immunol 21: 335-376.
6. Amati L, Pepe M, Passeri ME, Mastronardi ML, Jirillo E, et al. (2006) Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization. Curr Pharm Des 12: 4247-4254.
7. Sparwasser T, Koch ES, Vabulas RM, Heeg K, Lipford GB, et al. (1998) Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 28: 2045-2054.
8. Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC, (1998) Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol 161: 3042-3049.
9. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV, (1997) CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186: 1623-1631.
10. Warren TL, Bhatia SK, Acosta AM, Dahle CE, Ratliff TL, et al. (2000) APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells. J Immunol 165: 6244-6251.
11. Carbone FR, Kurts C, Bennett SR, Miller JF, Heath WR, (1998) Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today 19: 368-373.
12. Datta SK, Redecke V, Prilliman KR, Takabayashi K, Corr M, et al. (2003) A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J Immunol 170: 4102-4110.
13. Baggiolini M, Dewald B, Moser B, (1997) Human chemokines: an update. Annu Rev Immunol 15: 675-705.
14. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, et al. (2003) Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187: 129-34.
15. Dearman RJ, Cumberbatch M, Maxwell G, Basketter DA, Kimber I, (2009) Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells. Immunology 126: 475-484.
16. Vollmer J, Jurk M, Samulowitz U, Lipford G, Forsbach A, et al. (2004) CpG oligodeoxynucleotides stimulate IFN-gamma-inducible protein-10 production in human B cells. J Endotoxin Res 10: 431-438.
17. Enderlin M, Kleinmann EV, Struyf S, Buracchi C, Vecchi A, et al. (2009) TNF-alpha and the IFN-gamma-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma. Cancer Gene Ther 16: 149-60.
18. Weinzierl AO, Szalay G, Wolburg H, Sauter M, Rammensee HG, et al. (2008) Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis. J Virol 82: 8149-60.
19. Uicker WC, Doyle HA, McCracken JP, Langlois M, Buchanan KL, (2005) Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans. Med Mycol 43: 27-38.
20. Pertl U, Luster AD, Varki NM, Homann D, Gaedicke G, et al. (2001) IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy. J Immunol 166: 6944-6951.
21. Muller K, van Zandbergen G, Hansen B, Laufs H, Jahnke N, et al. (2001) Chemokines, natural killer cells and granulocytes in the early course of Leishmania major infection in mice. Med. Microbiol. Immunol.(Berlin) 190: 73-76.
22. Gupta G, Bhattacharjee S, Bhattacharyya S, Bhattacharya P, Adhikari A, et al. (2009) CXC chemokine-mediated protection against visceral leishmaniasis: involvement of the proinflammatory response. J Infect Dis 200: 1300-1310.
23. Taub DD, Longo DL, Murphy WJ, (1996) Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice. Blood 87: 1423-1431.
24. Dar WA, Knechtle SJ, (2007) CXCR3-mediated T-cell chemotaxis involves ZAP-70 and is regulated by signalling through the T-cell receptor. Immunology 120: 467-485.
25. Thapa M, Carr DJ, (2009) CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration. J Virol 83: 9486-9501.
26. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176: 1693-1702.
27. Murray HW, Miralles GD, Stoeckle MY, McDermott DF, (1993) Role and effect of IL-2 in experimental visceral leishmaniasis. J Immunol 151: 929-938.
28. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, et al. (2002) IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for CXCL10 in effector T cell generation and trafficking. J Immunol 168: 3195-3204.
29. Kim TG, Kim CH, Won EH, Bae SM, Ahn WS, et al. (2004) CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model. Immunology 112: 117-125.
30. Wang JC, Livingstone AM, (2003) Cutting edge: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo. J Immunol 171: 6339-43.
31. Griffiths GM, Alpert S, Lambert E, McGuire J, Weissman IL, (1992) Perforin and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis. Proc Natl Acad Sci U S A 89: 549-553.
32. Russo DM, Chakrabarti P, Higgins AY, (1999) Leishmania: naive human T cells sensitized with promastigote antigen and IL-12 develop into potent Th1 and CD8(+) cytotoxic effectors. Exp Parasitol 93: 161-170.
33. Morris L, Troutt AB, McLeod KS, Kelso A, Handman E, et al. (1993) Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis. Infect Immun 61: 3459-3465.
34. Colmenares M, Kima PE, Samoff E, Soong L, McMahon-Pratt D, (2003) Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection. Infect Immun 71: 3172-3182.
35. Nateghi Rostami M, Keshavarz H, Edalat R, Sarrafnejad A, Shahrestani T, et al. (2010) CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis. PLoS Negl Trop Dis 4: e845.
36. Hernández-Ruiz J, Salaiza-Suazo N, Carrada G, Escoto S, Ruiz-Remigio A, et al. (2010) CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists. PLoS Negl Trop Dis 4: e871.
37. Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, et al. (2006) Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 440: 890-895.
38. Heymann F, Meyer-Schwesinger C, Hamilton-Williams EE, Hammerich L, Panzer U, et al. (2009) Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest 119: 1286-1297.
39. Uzonna JE, Joyce KL, Scott P, (2004) Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. J Exp Med 199: 1559-66.
40. Belkaid Y, Von Stebut E, Mendez S, Lira R, Caler E, et al. (2002) CD8+ T cells are required for primary immunity in C57BL/6 mice followinglow-dose, intradermal challenge with Leishmania major. J Immunol 168: 3992-4000.
41. Martin S, Pahari S, Sudan R, Saha B, (2010) CD40 signaling in CD8+CD40+ T cells turns on contra-T regulatory cell functions. J Immunol 184: 5510-5518.
42. Vasquez RE, Soong L, (2006) CXCL10/gamma interferon-inducible protein 10-mediated protection against Leishmania amazonensis infection in mice. Infect Immun 74: 6769-77.
43. Gupta G, Majumdar S, Adhikari A, Bhattacharya P, Mukherjee AK, et al. (2011) Treatment with IP-10 induces host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice. Med Microbiol Immunol 200: 241-53.